Anthrax Vaccine: Changes to the Manufacturing Process
Description:
Testimony issued by the General Accounting Office with an abstract that begins "The original anthrax vaccine was developed in the 1950s and was first produced on a large scale by Merck. The BioPort Corporation in Michigan is now the sole facility in the United States capable of producing the vaccine. The Food and Drug Administration (FDA) licenses biological products and their production facilities. The manufacturer is required to comply with current good manufacturing practices, which regulate…
more
Date:
October 23, 2001
Creator:
United States. General Accounting Office.
Item Type:
Refine your search to only
Text
Partner:
UNT Libraries Government Documents Department